Abstract:Abstract Background: Expression of the androgen receptor (AR) is associated with androgen-dependent proliferation arrest and terminal differentiation of normal prostate epithelial cells. Additionally, activation of the AR is required for survival of benign luminal epithelial cells and primary cancer cells. Androgen deprivation therapy (ADT) leads to apoptosis in both benign and cancerous tissue. Cancer cell escape from ADT is known as castration-resistant prostate cancer (CRPC). In the course of CRPC development the AR typically switches from being a cell-intrinsic inhibitor of normal prostate epithelial cell proliferation to becoming an oncogene that is critical for prostate cancer cell proliferation. Methods: Immortalized human prostate basal epithelial EP156T cells and progeny cells that underwent epithelial to mesenchymal transition (EMT), primary prostate epithelial cells (PrECs) and prostate cancer cell lines LNCaP, VCaP and 22Rv1 were used to examine context dependent restriction and activation of the AR and classical target genes, such as KLK3. Genome-wide gene expression analyses and single cell protein analyses were applied to study the effect of different contexts. Results: A variety of growth conditions were tested and found unable to activate AR expression and transcription of classical androgen-dependent AR target genes, such as KLK3, in prostate epithelial cells with basal cell features or in mesenchymal type prostate cells. The restriction of androgen and AR dependent transcription of classical target genes in prostate basal epithelial cells was at the level of AR expression. Exogenous AR expression was sufficient for androgen-dependent transcription of AR target genes in prostate basal epithelial EP156T-AR cells, but did not exert a positive feedback on endogenous AR expression. Mesenchymal type prostate EPT3-AR cells with exogenous AR expression, in contrast to epithelial type EP156T-AR cells, were androgen non-responsive and were unable to produce detectable PSA in the culture supernatants even with higher levels of exogenous AR protein than in EP156T-AR and LNCaP cells for up to 2 weeks in androgen containing growth medium. The restricted PSA expression in the mesenchymal context suggests that if ADT increases the pool of mesenchymal type prostate cancer cells, then this might go undetected during PSA monitoring of disease progression. Citation Format: Jan Roger Olsen, Waqas Azeem, Margrete R. Hellem, Kristo Marvyin, Yaping Hua, Yi Qu, Lisha Li, Biaoyang Lin, XiSong Ke, Anne Margrete Oyan, Karl-Henning Kalland. Context dependent regulatory patterns of the androgen receptor (AR) and androgen receptor target genes. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 1824.

Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor

Interleukin-6 Induces Androgen Responsiveness in Prostate Cancer Cells Through Up-Regulation of Androgen Receptor Expression.

Interleukin-6 Promotes Androgen-Independent Growth in LNCaP Human Prostate Cancer Cells.

Interleukin-4 Enhances Prostate-Specific Antigen Expression by Activation of the Androgen Receptor and Akt Pathway

Relationship between glucocorticoid receptor signal pathway and androgen-independent prostate cancer.

IL-6 Signaling Link between Inflammatory Tumor Microenvironment and Prostatic Tumorigenesis

Inhibition of Interleukin-6 with CNTO328, an Anti-Interleukin-6 Monoclonal Antibody, Inhibits Conversion of Androgen-Dependent Prostate Cancer to an Androgen-Independent Phenotype in Orchiectomized Mice.

Osteoblasts Induce Prostate Cancer Proliferation and PSA Expression Through Interleukin-6-mediated Activation of the Androgen Receptor

Androgen downregulation of miR-760 promotes prostate cancer cell growth by regulating IL6

Synergistic Activation of Androgen Receptor by Androgen and Luteinizing Hormone-Releasing Hormone in Prostatic Carcinoma Cells.

Identification of an IL‐1‐induced Gene Expression Pattern in AR+ PCa Cells That Mimics the Molecular Phenotype of AR− PCa Cells

Abstract 1824: Context Dependent Regulatory Patterns of the Androgen Receptor (AR) and Androgen Receptor Target Genes

Regulation of heat shock protein 70-1 expression by androgen receptor and its signaling in human prostate cancer cells.

IL‐1β is an Androgen‐Responsive Target in Macrophages for Immunotherapy of Prostate Cancer

Inflammation Induced by Lipopolysaccharide Advanced Androgen Receptor Expression and Epithelial-Mesenchymal Transition Progress in Prostatitis and Prostate Cancer.

IL-6 and PPARgamma signalling in human PC-3 prostate cancer cells

G-Protein Alpha-s And-12 Subunits Are Involved in Androgen-Stimulated PI3K Activation and Androgen Receptor Transactivation in Prostate Cancer Cells

Reciprocal Regulation of 5Alpha-Dihydrotestosterone, Interleukin-6 and Interleukin-8 During Proliferation of Epithelial Ovarian Carcinoma.

Interleukin-6 Polymorphism Is Associated With More Aggressive Prostate Cancer

RELA is Sufficient to Mediate Interleukin-1 Repression of Androgen Receptor Expression and Activity in an LNCaP Disease Progression Model.

MP06-05 UPREGULATED INTERLEUKIN 21 RECEPTOR ENHANCES PROLIFERATION AND EPITHELIAL-MESENCHYMAL TRANSITION PROCESS IN BENIGN PROSTATIC HYPERPLASIA